Fabrice Chouraqui

Fabrice Chouraqui is a prominent figure in the pharmaceutical and biotech industries with extensive experience in leadership roles. He currently serves as a Board Member at Orano Med, a company specializing in nuclear medicine.12

Professional Background

Chouraqui holds several key positions:

1. CEO-Partner at Flagship Pioneering, a Boston-based biotech investment fund.1
2. CEO of Cellarity, a Flagship Pioneering company focused on developing treatments for cellular dysfunction using biology, genomic sequencing, and artificial intelligence.1

Previous Experience

Prior to his current roles, Chouraqui had a distinguished career:

• Worked at Novartis for ten years, including serving as President of Novartis Pharmaceuticals in the USA from 2016 to 2020.1
• Began his career in R&D at Roussel Uclaf and Hoechst Marion Roussel, predecessors to Sanofi.1
• Held management positions in Europe and Asia at Bristol-Myers Squibb.1

Education

Chouraqui has a strong educational background in pharmacy and business:

• MBA from INSEAD (1999)13
• Doctorate in Pharmacy (PharmD) from the University of Paris V1
• Post-Graduate Degree in Quality Management from the University of Paris V1
• M.Sc. in Biological and Medicinal Sciences from the University of Paris V1

Role at Orano Med

As a Board Member at Orano Med, Chouraqui is part of the company's Governing Board, which consists of 8 members with diverse expertise in pharmaceuticals, biotech, and the nuclear sector.2 His experience in the pharmaceutical industry likely provides valuable insights to Orano Med's development in nuclear medicine.